Medicine and Dentistry
Plasmodium Knowlesi Malaria
96%
Malaria
88%
Plasmodium
64%
Plasmodium knowlesi
52%
Patient
44%
Parasite (Microbiology)
31%
Therapeutic Procedure
29%
Malaria Falciparum
27%
Species
26%
Diseases
25%
Plasmodium Vivax Malaria
24%
Incidence
21%
Infection
20%
Combination Therapy
19%
Artesunate
19%
Chloroquine
16%
Disease Severity
16%
Artemisinin
15%
Anemia
15%
Adult
14%
Association
14%
Polymerase Chain Reaction
13%
Age
12%
Parasitemia
12%
Erythrocyte
11%
Blood
11%
Death
10%
Microscopy
10%
Intravascular Hemolysis
10%
Inpatient
9%
Analysis
9%
Hospital
9%
Enalapril Maleate
8%
Parasite Clearance
8%
Mefloquine
7%
Antimalarial Agent
7%
Loop-Mediated Isothermal Amplification
6%
Serositis
6%
Cohort Effect
6%
Acute Kidney Injury
6%
Hemolysis
5%
Patient Referral
5%
Health
5%
Hemoglobin
5%
Gene
5%
Surveillance
5%
Arginine
5%
Polymerase Chain Reaction
5%
Assay
5%
Human
5%
Pharmacology, Toxicology and Pharmaceutical Science
Plasmodium Knowlesi Malaria
59%
Malaria
46%
Plasmodium knowlesi
28%
Plasmodium vivax
26%
Chloroquine
22%
Plasmodium
21%
Artemisinin
17%
Artesunate
16%
Plasmodium Vivax Malaria
16%
Diseases
15%
Parasite Clearance
14%
Acute Kidney Failure
13%
Randomized Controlled Trial
13%
Plasmodium falciparum
13%
Malaria Falciparum
12%
Infection
12%
Parasite
12%
Combination Therapy
11%
Elimination
9%
Microscopy
9%
Paracetamol
8%
Anemia
8%
Parasitemia
8%
Antimalarial Agent
8%
Artemether Plus Benflumetol
8%
Mefloquine
7%
Primaquine
7%
Creatinine
6%
Recurrent Disease
6%
Incidence
6%
Death
5%
Clinical Trial
5%
Immunology and Microbiology
Malaria
100%
Plasmodium knowlesi
45%
Plasmodium vivax
42%
Plasmodium
34%
Parasite
32%
Species
29%
Plasmodium falciparum
26%
Zoonotic
13%
Parasitemia
12%
Polymerase Chain Reaction
11%
Sample
8%
Age
8%
Spectrum
7%
Human
6%
Genetic Variability
6%
Antigenicity
6%
Protein Binding
6%
Biomass
6%
Inflammation
6%
Association
6%
Cross-Reactivity
6%
Electric Potential
6%
Blood Plasma
6%
Parasite Clearance
5%
Antigen
5%